My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

MaxCyte, Inc. - Common Stock (NQ:MXCT)

1.630 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MaxCyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

March 13, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

March 13, 2024

U.S. stock futures were mixed this morning, with the Nasdaq futures falling by around 20 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 12, 2024

Via Benzinga

MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

March 12, 2024

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Earnings Preview ↗

March 11, 2024

Via Benzinga

Recap: MaxCyte Q3 Earnings ↗

November 08, 2023

Via Benzinga

Earnings Scheduled For March 12, 2024 ↗

March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Via Benzinga

MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results

March 04, 2024

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences

February 09, 2024

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers

January 30, 2024

Wugen to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its programs for hematologic and solid tumor cancers

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs

January 23, 2024

Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T product candidate for the treatment of blood cancer...

From MaxCyte, Inc

Via GlobeNewswire

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday ↗

January 09, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

Via Benzinga

Topics Stocks

Why Cell Engineering Company MaxCyte Shares Are Up Today ↗

January 09, 2024

MaxCyte Inc (NASDAQ: MXCT) shares are trading higher by over 9% after the company disclosed strong preliminary Q4 and full-year

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 08, 2024

Via Benzinga

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results

January 08, 2024

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline

January 03, 2024

Lion TCR to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to develop and scale TCR-T cell therapies for solid tumors and viral-related diseases.

From MaxCyte, Inc; Lion TCR

Via GlobeNewswire

MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director

January 02, 2024

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023

December 11, 2023

From MaxCyte, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member

November 16, 2023

MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicines

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance

November 08, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte to Participate in Two Upcoming Investor Conferences

November 06, 2023

From MaxCyte, Inc

Via GlobeNewswire

Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline ↗

October 05, 2023

MaxCyte Inc (NASDAQ: MXCT) shares plummeted after the company released preliminary Q3 revenue of $7.8 million – 8.0 million, a Y/Y decrease of 25 -27%, due to continued reduced

Via Benzinga

Crude Oil Down 2%; ConAgra Brands Earnings Top Views ↗

October 05, 2023

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. The Dow traded down 0.12% to 33,088.44 while the NASDAQ fell 0.23% to...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 05, 2023

Via Benzinga

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 05, 2023

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...

Via Benzinga

Why Shares of MaxCyte Are Plummeting on Thursday ↗

October 05, 2023

The biotech company reduced full-year guidance and expects so-so third-quarter revenue.

Via The Motley Fool

Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast ↗

October 05, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.45% to 32,980.31 while the NASDAQ fell 0.62% to 13,154.24. The...

Via Benzinga

Topics Stocks

BB Stock Alert: What to Know as BlackBerry Plans IPO for IoT Division ↗

October 05, 2023

BlackBerry stock is a hot topic among BB shareholders today alongside news the company is considering an IPO for its IoT business.

Via InvestorPlace

Topics Initial Public Offering

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 05, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.